March 19, 2024CorporateTerumo Blood and Cell Technologies partners with CiRA Foundation to develop automated iPS cell manufacturingiPS cell manufacturing organization researchers to integrate Terumo Blood and Cell Technologies’ Quantum Flex, expertise through collaboration
March 11, 2024FinancialNotice Concerning the Status and Completion of the Acquisition of Own Shares and Cancellation of Treasury Stock (PDF 130.35 KB)
March 11, 2024FinancialNotice Concerning Partial Amendment to “Notice Concerning Share Split and Partial Amendment to the Articles of Incorporation” (PDF 115.61 KB)
Corporate Governance /about/governance Compliance /about/compliance Leadership Team /about/leadership Business Risks Major risks that may affect the business performance and financial position of the Terumo Group are described. /investors/management/risk IR Policy /investors/management/ir_policy Disclaimer /investors/disclaimer